Home/Filings/4/0000899243-22-029062
4//SEC Filing

Leen Ann M. 4

Accession 0000899243-22-029062

CIK 0001754068other

Filed

Aug 16, 8:00 PM ET

Accepted

Aug 17, 6:04 PM ET

Size

6.2 KB

Accession

0000899243-22-029062

Insider Transaction Report

Form 4
Period: 2022-08-16
Leen Ann M.
Chief Scientific Officer
Transactions
  • Award

    Common Stock

    2022-08-16+15,00043,000 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    2,288,154
Footnotes (2)
  • [F1]The shares reported in this transaction represent restricted stock units ("RSUs") issued under the AlloVir, Inc. 2020 Stock Option and Grant Plan (the "Plan"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs shall vest on August 16, 2023, with the remainder vesting in twelve equal quarterly installments thereafter.
  • [F2]Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Issuer

Allovir, Inc.

CIK 0001754068

Entity typeother

Related Parties

1
  • filerCIK 0001763026

Filing Metadata

Form type
4
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 6:04 PM ET
Size
6.2 KB